About InterValve
InterValve is a company based in Minneapolis (United States) founded in 2008 was acquired by Venus MedTech in June 2017. InterValve has raised $11.13 million across 4 funding rounds from investors including Venus MedTech and Oxford Finance. InterValve operates in a competitive market with competitors including Insightra, Laguna Tech USA, TNMI, Hybernia Medical and AR Baltic Medical, among others.
- Headquarter Minneapolis, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Intervalve Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$11.13 M (USD)
in 4 rounds
-
Latest Funding Round
$3 M (USD), Debt – Conventional
Jan 21, 2015
-
Investors
Venus MedTech
& 1 more
-
Employee Count
Not available
-
Acquired by
Venus MedTech
(Jun 13, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of InterValve
InterValve has successfully raised a total of $11.13M across 4 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $3 million completed in January 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in InterValve
InterValve has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Venus MedTech and Oxford Finance.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture debt firm focused on the life sciences sector
|
Locked | Locked | Locked | |
|
Transcatheter aortic and pulmonic valves are developed for cardiovascular procedures.
|
Locked | Locked | Locked |
Investor details for InterValve
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by InterValve
Investment portfolio details for InterValve
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - InterValve
Detailed financials for InterValve
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Intervalve Comparisons
Peer comparison for InterValve
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of InterValve
InterValve operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insightra, Laguna Tech USA, TNMI, Hybernia Medical and AR Baltic Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Intra-aortic balloon catheters are developed for cardiology surgeries.
|
|
| Locked | Locked | Locked |
Heart valve systems are developed to treat valve regurgitation.
|
|
| Locked | Locked | Locked |
Medical devices are developed and manufactured for surgical procedures.
|
|
| Locked | Locked | Locked |
Solutions for acute ischemic stroke treatment are developed.
|
|
| Locked | Locked | Locked |
Manufactures medical devices like drug-coated balloons for healthcare applications.
|
Detailed competitors of InterValve
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Intervalve
Complete news archive for InterValve
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about InterValve
InterValve was founded in 2008 and raised its 1st funding round 4 years after it was founded.
InterValve is headquartered in Minneapolis, United States. It is registered at Minneapolis, Minnesota, United States.
InterValve is a funded company, having raised a total of $11.13M across 4 funding rounds to date.
InterValve was founded in 2008 and is based in Minneapolis, United States. Medical devices for percutaneous and trans-apical aortic valve replacement procedures are developed by the company within the cardiology sector. The main product, V8, functions as an aortic valvuloplasty balloon catheter targeted at calcified aortic valve stenosis. Regulatory approval for V8 sales has been secured, supporting clinical applications in valve treatments.
InterValve's top competitors include Insightra, Synaptic Medical and Lutonix.
InterValve has 2 investors. Key investors include Venus MedTech, and Oxford Finance.